Mennella Michael A MD is categorized under Internal Medicine Doctors in Smithtown, NY and active since 2010.
Mennella Michael A MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Mennella at the company’s single location by writing to 496 Smithtown Bypass # Ll1, Smithtown, New York NY 11787 or by phoning (631) 724-6333. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mennella Michael A MD |
| Contact Person: | Michael Mennella |
| Address: | 496 Smithtown Bypass # Ll1, Smithtown, New York 11787 |
| Phone Number: | (631) 724-6333 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Mennella Michael A MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Mennella for inquiries that concern Mennella Michael A MD by calling the company number (631) 724-6333, as your correspondence is most welcome. Additionally, the physical location of the single location of Mennella Michael A MD can be found at the coordinates 40.82993,-73.19961 as well as the street address 496 Smithtown Bypass # Ll1 in Smithtown, New York 11787.
For its online presence, you may visit Mennella Michael A MD’s website at and engage with its social media outlets through on Twitter and on Facebook.